Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.

Auteurs : Lan Q, Peyvandi S, Duffey N, Huang YT, Barras D, Held W, Richard F, Delorenzi M, Sotiriou C, Desmedt C, Lorusso G, Rüegg C
Année : 2019
Journal : Oncogene
Volume : 38
Pages : 2814-2829